Hypoxia Enhances the Senescence Effect of Bortezomib—The Proteasome Inhibitor—On Human Skin Fibroblasts
Figure 1
The viability of fibroblasts treated with different concentrations of bortezomib for 12 h, 24 h, and 48 h. The results are mean for pooled triplicate values from three independent experiments. Statistical significance was considered if *.
